What if my lung-dominant connective tissue disease (LD-CTD) patient eventually met criteria for a definite CTD: The role of prognosis!

Daniel Antunes Silva Pereira (Sao Paulo, Brazil), Daniel Antunes Silva Pereira, Olivia Meira Dias, Mariana Sponholz Araujo, Leticia Kawano-Dourado, Carolina Salim Freitas, Alexandre De Melo Kawassaki, Bruno Gratziou, Carlos R.R. Carvalho, Ronaldo Adib Kairalla

Source: International Congress 2015 – Connective tissue disorders
Session: Connective tissue disorders
Session type: Thematic Poster Session
Number: 3799
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Daniel Antunes Silva Pereira (Sao Paulo, Brazil), Daniel Antunes Silva Pereira, Olivia Meira Dias, Mariana Sponholz Araujo, Leticia Kawano-Dourado, Carolina Salim Freitas, Alexandre De Melo Kawassaki, Bruno Gratziou, Carlos R.R. Carvalho, Ronaldo Adib Kairalla. What if my lung-dominant connective tissue disease (LD-CTD) patient eventually met criteria for a definite CTD: The role of prognosis!. Eur Respir J 2015; 46: Suppl. 59, 3799

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Idiopathic non-specific interstitial pneumonia (iNSIP): do the patients develop connective tissue disease (CTD) during follow-up?
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

ILD-India registry: Idiopathic pulmonary fibrosis (IPF) and connective tissue disease (CTD) associated interstitial lung disease (CTD-ILD)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Are there any clinical differences between SSc-ILD and UCTD suspected of SSc -ILD?
Source: International Congress 2015 – Connective tissue disorders
Year: 2015


Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD)
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Study of factors affecting mortality in ILD cases over 2 years
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Clinical analysis of lung manifestation in Sjögren's syndrome
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013

Usefulness of a myositis antibody immunoblot in diagnosis of connective tissue disease (CTD) related interstitial lung disease (ILD)
Source: International Congress 2014 – ILDs 4
Year: 2014


A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Interstitial lung disease
Source: Eur Respir Rev 2013; 22: 26-32
Year: 2013



The impact of definition of ILD on WHO group Classification of PH in scleroderma
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Evaluation and treatment of interstitial lung involvement in connective tissue diseases: a clinical update
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=27
Year: 2005

Detection of anti DFS70 antibodies in patients with interstitial lung disease (ILD) with and without connective tissue disease (CTD)
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Rituximab in severe, progressive interstitial lung disease
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Chemical exposure triggering connective tissue disease with lung involvement
Source: International Congress 2015 – Occupational disease: clinical cases and series
Year: 2015


Neoplasia in patients with ILD; shortened survival
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


Pattern and impact of rheumatology referral in patients with ILD and autoimmune features
Source: International Congress 2016 – Connective tissue disorders
Year: 2016


Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies
Source: International Congress 2016 – Connective tissue disorders
Year: 2016